Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DSNKY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 10.48B
March 31, 2026 10.46B
December 31, 2025 10.91B
September 30, 2025 11.19B
June 30, 2025 10.93B
March 31, 2025 10.86B
December 31, 2024 10.34B
September 30, 2024 11.35B
June 30, 2024 10.70B
March 31, 2024 11.15B
December 31, 2023 11.25B
September 30, 2023 10.68B
June 30, 2023 10.58B
March 31, 2023 10.86B
December 31, 2022 10.72B
September 30, 2022 10.14B
June 30, 2022 10.31B
March 31, 2022 11.13B
December 31, 2021 11.56B
September 30, 2021 11.76B
June 30, 2021 11.53B
March 31, 2021 11.51B
December 31, 2020 12.51B
September 30, 2020 12.63B
June 30, 2020 12.20B
Date Value
March 31, 2020 12.10B
December 31, 2019 12.24B
September 30, 2019 11.77B
June 30, 2019 11.64B
March 31, 2019 11.29B
December 31, 2018 11.26B
September 30, 2018 10.99B
June 30, 2018 10.94B
March 31, 2018 10.65B
December 31, 2017 10.66B
September 30, 2017 10.65B
June 30, 2017 10.60B
March 31, 2017 10.55B
December 31, 2016 10.51B
September 30, 2016 11.46B
June 30, 2016 11.56B
March 31, 2016 10.96B
December 31, 2015 10.75B
September 30, 2015 10.58B
June 30, 2015 10.44B
March 31, 2015
December 31, 2014 9.232B
September 30, 2014 9.419B
June 30, 2014 9.631B
March 31, 2014

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Astellas Pharma, Inc. 11.95B
AstraZeneca PLC 47.33B
Takeda Pharmaceutical Co., Ltd. 46.50B
Ono Pharmaceutical Co., Ltd. 5.334B
Shionogi & Co., Ltd. 10.90B

Shareholders Equity (Quarterly) Related Metrics